[144] IonQ, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice reports a proposed sale of 158,330 shares of common stock of the issuer through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $6,806,606.70. The shares were acquired on 02/24/2021 via previously exercised stock options and payment was recorded the same day. The filing lists prior sales by the same account in the past three months totaling 406,630 shares for $16,759,629.40. The notice includes the standard Rule 144 representation and references reliance on 10b5-1 sales in several prior transactions.

Positive

• Proposed sale is documented under Rule 144 with broker details provided (Morgan Stanley Smith Barney).
• Securities were acquired via previously exercised stock options on 02/24/2021, with payment noted the same day.
• Several prior 10b5-1 sales are explicitly identified, indicating use of prearranged trading plans for past transactions.

Negative

• Insider sold 406,630 shares in the past three months for total gross proceeds of $16,759,629.40.
• Proposed sale of 158,330 shares has an aggregate market value of $6,806,606.70, which could be perceived as insider monetization.

Insights

Securities Analyst

TL;DR: Routine insider Rule 144 notice for option-derived shares; prior 10b5-1 sales show material monetization but small relative to outstanding shares.

The filing documents a covered sale of 158,330 shares acquired by option exercise on 02/24/2021, with a reported aggregate market value of $6,806,606.70. Recent 10b5-1 programmed sales over the past three months total 406,630 shares yielding $16,759,629.40. Compared with the reported 296,837,796 shares outstanding, these disposals represent a very small percentage of the float, indicating routine liquidity management rather than a large-scale divestiture. The filing itself follows Rule 144 disclosure norms and names the executing broker.

Compliance / Risk Analyst

TL;DR: Compliance-focused filing; transactions appear documented under Rule 144 and several sales reference Rule 10b5-1 plans.

The notice states the seller represents no undisclosed material adverse information and indicates reliance on prior 10b5-1 sales for several transactions listed. Acquisition details show the securities originated from previously exercised options, with payment completed on the acquisition date. The form includes broker identification for the proposed sale, consistent with required broker disclosure. No other compliance exceptions or irregularities are disclosed in the provided content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	158330	6806606.70	296837796	09/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/24/2021	Previously Exercised Stock Options	Issuer			158330	02/24/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for THOMAS G. KRAMER 4505 Campus Drive College Park MD 20740	Common	08/06/2025	17776	733800.39
10b5-1 Sales for THOMAS G. KRAMER 4505 Campus Drive College Park MD 20740	Common	07/21/2025	47478	2264719.59
10b5-1 Sales for THOMAS G. KRAMER 4505 Campus Drive College Park MD 20740	Common	07/08/2025	43382	2070586.59
10b5-1 Sales for THOMAS G. KRAMER 4505 Campus Drive College Park MD 20740	Common	07/02/2025	72000	3042396.00
10b5-1 Sales for THOMAS G. KRAMER 4505 Campus Drive College Park MD 20740	Common	06/16/2025	216000	8232422.40
THOMAS G. KRAMER 4505 Campus Drive College Park MD 20740	Common	06/11/2025	9994	415704.43

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for IONQ (IONQ) report?

The Form 144 reports a proposed sale of 158,330 common shares on the NYSE with an aggregate market value of $6,806,606.70.

How were the shares to be sold acquired?

The shares were acquired on 02/24/2021 through previously exercised stock options, with payment recorded the same day.

What prior sales by the same seller are disclosed in the filing?

The filing lists six sales in the past three months totaling 406,630 shares for aggregate gross proceeds of $16,759,629.40; several are identified as 10b5-1 programmed sales.

Which broker is handling the proposed sale?

The broker named for the proposed sale is Morgan Stanley Smith Barney LLC, Executive Financial Services, New York, NY.

What representation does the seller make in the Form 144?

The seller represents they do not know any material adverse information about the issuer that has not been publicly disclosed and notes reliance on any applicable 10b5-1 plan dates where used.

How large are these transactions relative to outstanding shares?

The filing shows 296,837,796 shares outstanding; the proposed 158,330-share sale and recent 406,630-share disposals are a small fraction of that total.